Trial Information

Summary: A Study to Investigate the Effect of Two Doses of CREON on Maldigestion in Patients with Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis

Solvay Pharmaceuticals, Inc. is carrying out a research study to find out how well an investigational drug called pancrealipase delayed release capsules (a reformulation of CREON capsules) works as a possible treatment for poor digestion due to chronic pancreatitis.

Compensation for time and travel will be provided.

The study requires that you must be:

• 18 years or older
• Suffering from chronic pancreatitis with a documented diagnosis
• Interested in participating in a clinical study that closely monitors your health

Study participation includes, at no cost to you:

• Study visits with experienced medical professionals
• Study drug for up to 7 months
• Consultation with a licensed dietitian

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:46 AM